All told, over the long-term, Cramer thinks GW Pharma shareholders may be facing significant opportunity.
-----------------------------------------------------------
Read more from Mad Money with Jim Cramer
These 2 companies executing perfectly
Stock with monster multi-year gains?
Wall Street, this BUD's for you!
-----------------------------------------------------------
"And if you're worried about investing in medical marijuana, let me tell you that a bunch of firms have endorsed this stock, including Bank of America, Cowen, Piper Jaffray and Leerink Swann," Cramer said.
Just one caveat, "the company is not yet profitable, however, they do have a nice, consistent revenue stream," Cramer said. Therefore, it's for speculation only.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
So what 's the difference Between A British Based MMJ company and a Canadian MMJ?
Something is fishy with yesterday's article IMO>